secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cogent Biosciences, Inc. (COGT)
CIK:        0001622229
Form:       8-K
Filed at:   2025-06-05T23:59:59+00:00
Accession:  0001193125-25-135337
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cogent stockholders approve officer exculpation; annual meeting results filed
-----------------------------------------------------------------------------

- Approved amendment to certificate of incorporation to exculpate officers: 86,181,373 for, 4,422,462 against.
- Re-elected directors Karen Ferrante (68,418,781 for) and Matthew E. Ros (77,274,345 for).
- Ratified PricewaterhouseCoopers as auditor with 101,115,649 votes for.
- Advisory vote on executive compensation approved: 89,797,699 for, 808,715 against.
- Company presenting at Jefferies Global Healthcare Conference on June 5, 2025 (details in corporate presentation).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1622229/000119312525135337/0001193125-25-135337-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1622229/000119312525135337/d20143d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-135337

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer